UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025823
Receipt number R000029696
Scientific Title Risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome
Date of disclosure of the study information 2017/01/24
Last modified on 2023/02/01 19:14:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome

Acronym

RRSO for HBOC

Scientific Title

Risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome

Scientific Title:Acronym

RRSO for HBOC

Region

Japan


Condition

Condition

Hereditary breast and ovarian caccer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The Preventing treatment of the ovarian cancer in BRCA1 and BRCA2 mutation carriers

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The Preventing treatment of he ovarian cancer high risk case (BRCA1 and BRCA2 mutation carrier)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

abdominal or laparoscopic bilateral salpingo-oohorectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

BRCA1 and BRCA2 mutation carrier

Key exclusion criteria

BRCA1 and BRCA2 gene mutation negative case

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Kana
Middle name
Last name Iwai

Organization

Nara Medical University

Division name

Gynecology and Obstetrics

Zip code

6348521

Address

840, Shijo-Cho, Kashihara City 6348521 Nara Japan

TEL

0744223051

Email

iwaikana@naramed-u.ac.jp


Public contact

Name of contact person

1st name Kana
Middle name
Last name Iwai

Organization

Nara Medical University

Division name

Gynecology and Obstetrics

Zip code

634-8521

Address

840, Shijo-Cho, Kashihara City 6348521 Nara Japan

TEL

0744223051

Homepage URL


Email

iwaikana@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University

Address

840, Shijo-Cho, Kashihara City 6348521 Nara Japan

Tel

0744-22-3051

Email

iwaikana@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

奈良県立医科大学(奈良)


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2014 Year 09 Month 10 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 24 Day

Last modified on

2023 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029696